Outsourcing Outlook

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-01-2001
Volume 2001 Supplement
Issue 2

The consolidation of the contract manufacturing industry has spread to the parenteral fill-finish segment, with two deals announced just before this year's Fourth of July holiday.

External Link - article-5239.pdf

Articles in this issue
Creating a Successful Partnership with a Contract Manufacturer
Outsourcing Outlook
Creative Solutions in Client-CRO Relationships
Third-Party Technology Transfer
The Squeeze in Contract Manufacturing
Preparing Requests for Quotations for Commercial Pharmaceutical Manufacturing
Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies
Stakes Rise for Blown Batches
Partnerships in Drug Discovery
Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

New Almac Pharma Services Commercial Manufacturing Facility Opens in Northern Ireland

Patrick Lavery
March 11th 2025
Article

The company’s 100,000-sq.-ft. space is expected to enhance its capabilities for commercial oral dose treatment manufacturing in a variety of therapeutic areas.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Adragos Pharma Completes Liquid Filling Line Installation in Germany

Patrick Lavery
March 7th 2025
Article

The €4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine.

Drug Solutions Podcast: Examining the State of Biopharma Investment

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter
June 6th 2023
Podcast

In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CordenPharma Selects Switzerland Site for Peptide Manufacturing Facility

Patrick Lavery
March 5th 2025
Article

The company first announced its intention to build the state-of-the-art facility as part of a €900 million investment in July 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Nelson Labs Launches Rapid Sterility Testing, Cutting Incubation Times

Patrick Lavery
March 4th 2025
Article

The company now performs product-sterility testing through rapid microbiological methods at two laboratory sites in the United States and one in Germany.